Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

doi:10.3748/wjg.v27.i26.4045

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12963)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-9) series.

Item

Count

PDF

916

WORD

242

HTML

9865

Tables (1-9)

309

Sum=11332

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

586

Download

1045

Sum=1631

Jul 14, 2021 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (55)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 14, 2021; 27(26): 4045-4087
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4045

Table 6 Pancreatic cyst fluid biomarker studied in relation to high grade dysplasia and pancreatic cancer diagnosis

Type	Candidate marker
Protein	CEA[383,384,399,402-407], Glucose[385], MUC4[386,412], PGE2[387,388], IL-1B[386,387], PGE synthetase 2[386], IL-4[389], CA72-4[389], sFASL[389], MMP9[389] AREG[390,391], SPINK1[392], mAB Das-1[393,394], IL-10[395], GM-CSF[395], MUC1[413], MUC2[413], MUC5AC[413]
RNA	MiRNA: miR-21[396], miR-221[396], miR-18a[397,398], miR-24[397,398],miR-30a-3p[397,398], miR-92a[397,398], miR-99b[397,398], miR-106b[397,398], miR-142-3p[397,398], miR-342-3p[397,398], and miR-532-3p[397,398]
Other	DNA based-KRAS mutations[399-407,409-411] GNAS mutations[409-411]

MiRNA: MicroRNA; CA72-4: Cancer antigen 72-4; sFASL: Soluble Fas; AREG: amphiregulin; SPINK1: serine peptidase inhibitor kazal type 1; GM-CSF: granulocyte macrophage colony-stimulating factor.

Citation: O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087
URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4045.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4045